TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Cash Flow

Teva pharmaceutical industries ltd (TEVA)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08	Sep'08	Jun'08	Mar'08
Operating activities:
Net income (loss)
-878	-1,000	-4,319	-4,208	-3,703	-2,472	-10,959	-10,152	-15,956	-16,449	-5,693	-5,893	319	311	1,783	1,489	1,786	1,597	1,793	2,540	2,746	3,042	2,725	2,568	1,367	1,253	1,156	366	1,681	1,910	2,135	3,137	2,858	2,768	3,036	3,170	3,390	3,339	2,946	2,544	2,267	2,004	932	917	927	615	0	0	0
Adjustments to reconcile net income (loss) to net cash provided by operations:
Acquisition of research and development in process
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Depreciation and amortization
1,678	1,722	1,688	1,749	1,778	1,842	1,988	2,041	2,139	2,112	1,916	1,966	1,699	1,524	1,527	1,265	1,278	1,308	1,342	1,388	1,439	1,508	1,575	1,633	1,659	1,642	1,599	1,592	1,576	1,708	1,647	1,482	1,322	1,069	987	999	1,008	977	967	962	986	908	785	658	570	490	0	0	0
Impairment of long-lived assets
2,013	1,778	5,422	5,738	5,678	5,621	21,819	21,703	21,303	20,882	1,595	1,219	1,643	1,645	641	799	307	361	513	477	453	387	537	517	510	524	690	1,040	999	1,071	747	282	277	201	124	135	135	124	0	0	0	-	-	-	-	107	0	0	0
Venezuela impairment of net monetary assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in operating assets and liabilities
757	896	1,086	1,611	2,036	1,823	1,449	1,562	1,440	1,645	2,933	1,520	1,102	116	-1,364	146	-599	-967	-1,210	-1,793	-1,095	-290	-142	579	-660	-968	-1,057	-2,080	-751	-414	-567	452	-340	-594	-62	-602	143	205	4	-174	-174	-445	-160	102	-220	-76	0	0	0
Deferred income taxes – net and uncertain tax positions
-1,185	-985	-839	-710	-649	-837	-2,248	-2,693	-2,335	-2,331	-321	90	-151	15	-63	439	376	237	-100	-506	-355	-226	-937	-1,067	-1,341	-1,380	-853	-816	-384	-690	-781	-637	-856	-500	-342	-379	-249	-199	-88	-26	-78	-140	24	71	3	25	0	0	0
Amortization of purchased intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock-based compensation
115	119	132	142	159	155	149	135	123	133	147	147	140	124	114	109	112	117	120	112	107	95	83	82	63	64	63	66	80	82	83	85	88	91	90	86	85	80	72	70	63	54	58	59	60	63	0	0	0
Goodwill impairment
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of equity investment
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development in process
-	-	-	-	-	114	0	0	0	-	-	-	-	422	273	21	45	35	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18	0	0	0	-	-	-	-	-	-	-	-
Other items
-	-	-	-	-	-	-	0	20	-	151	106	4	14	601	-26	-25	-146	-894	-241	-132	-24	-28	-36	-64	-143	-183	-188	-147	-7	-4	-80	-95	-103	-79	-48	0	-57	0	0	0	-	-	-53	-42	-84	0	0	0
Net loss (gain) from sale of long-lived assets and investments
-8	18	-44	-75	-85	19	1,095	1,113	1,157	1,090	81	808	803	764	729	61	70	86	117	65	40	-1	-27	-16	-46	-18	-30	-13	5	3	-131	2	14	72	227	148	90	55	0	0	0	-	-	-	-	-	-	-	-
Other items
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
941	748	577	673	1,062	2,446	2,938	3,312	3,585	2,225	1,456	2,122	2,650	3,890	5,415	5,047	5,564	5,542	5,679	6,010	5,583	5,127	4,191	3,211	3,033	3,237	3,998	4,602	4,918	4,572	4,423	3,857	3,990	4,134	3,808	4,520	4,150	4,136	3,991	3,822	3,526	3,373	3,385	3,070	3,218	3,231	0	0	0
Investing activities:
Beneficial interest collected in exchange for securitized accounts receivables
1,493	1,487	1,471	1,511	1,653	1,735	1,692	1,612	1,392	1,282	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property, plant and equipment
528	525	619	589	613	651	705	778	835	874	940	949	931	901	816	765	759	772	824	866	889	929	943	959	992	1,031	1,044	1,065	1,094	1,104	1,094	1,121	1,093	1,053	970	869	779	710	688	709	724	719	688	670	699	681	0	0	0
Proceeds from sale of long lived assets
338	343	179	183	77	890	2,750	2,833	2,889	3,477	1,809	3,448	3,412	2,002	1,816	128	444	524	547	489	260	196	171	179	62	187	237	281	281	264	304	271	320	279	216	256	717	700	782	814	309	271	769	1,533	2,055	3,381	0	0	0
Purchases of investments and other assets
-	-	-	-	-	119	62	242	250	200	359	458	458	481	393	105	1,914	2,003	2,008	2,143	434	324	245	163	64	160	285	289	297	201	148	125	154	217	163	153	286	436	574	793	645	433	564	842	1,448	2,155	0	0	0
Other investing activities
-40	-58	-36	-81	-45	-11	-29	7	270	282	504	513	252	212	-36	-31	-11	5	30	30	18	30	39	45	73	104	109	117	96	93	77	71	77	49	60	69	58	58	60	50	42	35	43	13	-37	-67	0	0	0
Acquisitions of subsidiaries, net of cash acquired
-	-	-	-	-	-	-	-	-	-	-	-	-	36,148	35,879	2,360	5,545	3,309	3,304	3,461	200	363	363	202	202	39	0	0	0	-	-	-	-	6,561	1,349	5,397	5,397	4,951	0	0	0	-	-	-	-	4,749	0	0	0
Net cash provided by investing activities
1,335	1,355	999	1,122	1,099	1,866	3,704	3,461	2,969	3,446	2,072	-30,333	-30,472	-34,405	-35,236	-3,071	-7,763	-5,565	-5,619	-6,011	-1,281	-1,450	-1,419	-1,190	-1,269	-1,147	-1,240	-1,190	-1,206	-1,134	-6,216	-7,161	-7,119	-7,601	-2,326	-6,232	-5,803	-5,455	-5,502	-738	-1,102	-916	-4,509	-4,327	-4,394	-4,137	0	0	0
Financing activities:
Redemption of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	814	814	814	859	45	0	0	0	-	-	-	-	-	-	-	-
Repayment of senior notes and loans and other long-term liabilities
4,518	3,944	2,172	1,314	1,329	7,446	0	0	0	-	-	-	-	999	94	96	1,104	2,521	2,519	2,522	1,530	839	1,925	1,936	2,138	3,133	3,034	3,041	3,914	2,213	1,715	1,893	787	751	224	1,054	1,925	1,972	2,087	1,137	339	325	224	163	211	156	0	0	0
Proceeds from senior notes and loans, net of issuance costs
-	-	-	-	-	4,434	0	0	0	-	-	-	-	25,252	25,202	-50	-49	2,099	2,148	2,149	2,147	0	336	336	336	338	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	445	340	313	305	39	0	0	0
Proceeds From Senior Notes Net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,723	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-
Purchase of treasury shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	439	939	939	939	500	0	0	297	497	991	991	828	1,161	817	1,071	1,032	899	848	594	499	99	0	0	0	-	-	-	-	-	-	-	-
Net change in short-term debt
-	-	-	-	-	-260	-315	-467	-594	-1,683	-948	-237	610	1,998	-203	-1,627	50	29	1,535	2,303	-704	-385	12	105	740	384	22	-280	-2,655	-2,492	-3,543	-1,820	121	-124	560	131	542	626	-881	-2,005	-1,866	-2,002	41	145	-287	30	0	0	0
Tax withholding payments made on shares and dividends
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefit on options exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23	27	30	33	0	0	0
Other financing activities
0	-11	-58	-60	-63	-57	-18	-63	-72	-74	-95	-88	-145	-169	-157	-126	-161	-178	-154	-151	-49	-9	-16	9	14	23	25	7	6	5	2	1	2	5	6	8	9	14	0	0	0	-	-	-	-	-	-	-	-
Dividends paid on ordinary shares
-	-	-	-	-	-	-	-	-	901	1,160	1,377	1,342	1,303	1,247	1,194	1,172	1,155	1,137	1,144	1,155	1,156	1,160	1,130	1,099	1,089	1,027	1,000	962	855	831	798	771	800	782	745	706	668	638	597	567	529	476	447	419	387	0	0	0
Dividends paid on preferred shares
-	-	-	-	-	-	-	-	-	260	259	259	260	255	191	126	60	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of options by employees
-	-	-	-	-	-	-	-	-	-	-	-	-	35	83	150	235	388	563	562	582	514	352	288	187	91	19	8	4	14	40	59	60	71	98	86	131	180	183	220	200	169	209	221	197	192	0	0	0
Proceeds from issuance of ordinary shares, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	329	3,620	3,620	3,620	3,291	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	329	3,620	3,620	3,620	3,291	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-2,437	-1,926	-2,184	-1,428	-1,449	-3,351	-5,358	-5,478	-6,073	-5,750	-3,945	22,252	23,182	25,217	30,633	4,171	4,979	4,805	-503	258	-1,648	-2,375	-2,401	-2,328	-2,257	-3,883	-2,998	-3,312	-3,325	-1,678	2,148	3,416	3,493	3,336	-1,329	-2,231	-22	573	933	240	-2,416	-2,265	-89	724	1,222	1,358	0	0	0
Translation adjustment on cash and cash equivalents
-8	16	-26	-63	-157	-142	-89	-33	37	54	-460	-426	-424	-660	-183	-231	-212	-62	-102	-138	-159	-114	-46	11	0	-48	-44	-43	-55	23	-8	-63	-23	-21	-3	228	40	-1	-85	-231	-2	-51	-43	-190	-205	-86	0	0	0
Net change in cash and cash equivalents
-169	193	-634	304	555	819	1,195	1,262	518	-25	-877	-6,385	-5,064	-5,958	629	5,916	2,568	4,720	-545	119	2,495	1,188	325	-296	-493	-1,841	-284	57	332	1,783	347	49	341	-152	150	-3,715	-1,635	-747	-663	3,093	6	141	-1,256	-723	-159	366	0	0	0
Net change in operating assets and liabilities:
Decrease (increase) in working capital items
757	896	1,086	1,611	2,036	1,823	1,449	1,562	1,440	1,645	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0